During a system upgrade from Friday, Dec. 5, through Sunday, Dec. 7, the AAFP website, on-demand courses and CME purchases will be unavailable.
Rationale and Comments
Colposcopy for low-grade abnormalities in this group does not detect recurrence unless there is a visible lesion and is not cost effective.
Sponsoring Organizations
Society of Gynecologic Oncology
Sources
Expert consensus
Disciplines
Gynecologic
Oncologic
References
Rimel BJ, Ferda A, Erwin J, Dewdney SB, Seamon L, Gao F, DeSimone C, Cotney KK, Huh W, Massad LS. Cervicovaginal cytology in the detection of recurrence after cervical cancer treatment. Obstet Gynecol. 2011;118:548-53.
Tergas A HL, Guntupalli SR, Huh WK, Massad LS, Fader AN, Rimel BJ. A cost analysis of colposcopy following abnormal cytology in posttreatment surveillance for cervical cancer. Gynecol Oncol. 2013.